GB0807451D0 - Inhibitors of PLK - Google Patents

Inhibitors of PLK

Info

Publication number
GB0807451D0
GB0807451D0 GBGB0807451.0A GB0807451A GB0807451D0 GB 0807451 D0 GB0807451 D0 GB 0807451D0 GB 0807451 A GB0807451 A GB 0807451A GB 0807451 D0 GB0807451 D0 GB 0807451D0
Authority
GB
United Kingdom
Prior art keywords
plk
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0807451.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chroma Therapeutics Ltd
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Priority to GBGB0807451.0A priority Critical patent/GB0807451D0/en
Publication of GB0807451D0 publication Critical patent/GB0807451D0/en
Priority to PCT/GB2009/001019 priority patent/WO2009130453A1/en
Priority to JP2011505583A priority patent/JP2011518816A/ja
Priority to EP09735114A priority patent/EP2296662A1/en
Priority to US12/989,178 priority patent/US20110190306A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0807451.0A 2008-04-24 2008-04-24 Inhibitors of PLK Ceased GB0807451D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0807451.0A GB0807451D0 (en) 2008-04-24 2008-04-24 Inhibitors of PLK
PCT/GB2009/001019 WO2009130453A1 (en) 2008-04-24 2009-04-23 Inhibitors of plk
JP2011505583A JP2011518816A (ja) 2008-04-24 2009-04-23 Ｐｌｋインヒビター
EP09735114A EP2296662A1 (en) 2008-04-24 2009-04-23 Inhibitors of plk
US12/989,178 US20110190306A1 (en) 2008-04-24 2009-04-23 Inhibitors of PLK

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0807451.0A GB0807451D0 (en) 2008-04-24 2008-04-24 Inhibitors of PLK

Publications (1)

Publication Number Publication Date
GB0807451D0 true GB0807451D0 (en) 2008-05-28

Family

ID=39494145

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0807451.0A Ceased GB0807451D0 (en) 2008-04-24 2008-04-24 Inhibitors of PLK

Country Status (5)

Country Link
US (1) US20110190306A1 (https=)
EP (1) EP2296662A1 (https=)
JP (1) JP2011518816A (https=)
GB (1) GB0807451D0 (https=)
WO (1) WO2009130453A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0803747D0 (en) * 2008-02-29 2008-04-09 Martin Enzyme and receptor modulation
GB0903480D0 (en) 2009-02-27 2009-04-08 Chroma Therapeutics Ltd Enzyme Inhibitors
RU2012131124A (ru) 2009-12-23 2014-01-27 Элан Фармасьютикалз, Инк. Птеридиноны как ингибиторы polo-подобных киназ
GB201211310D0 (en) 2012-06-26 2012-08-08 Chroma Therapeutics Ltd CSF-1R kinase inhibitors
PL3222616T3 (pl) 2012-10-17 2019-12-31 Macrophage Pharma Limited N-[2-{4-[6-amino-5-(2,4-difluorobenzoilo)-2-oksopirydyn-1(2h)-ylo]-3,5-difluorofenylo}etylo)-L-alaninian tert-butylu lub jego sól, hydrat lub solwat
WO2016105518A1 (en) * 2014-12-23 2016-06-30 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
GB201713975D0 (en) 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use
TW202508595A (zh) 2023-05-04 2025-03-01 美商銳新醫藥公司 用於ｒａｓ相關疾病或病症之組合療法
US20250049810A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
AU2024360465A1 (en) 2023-10-12 2026-04-09 Revolution Medicines, Inc. Macrocyclic ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
TW202547461A (zh) 2024-05-17 2025-12-16 美商銳新醫藥公司 Ｒａｓ抑制劑
WO2025255438A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006021548A1 (de) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
EA200900593A1 (ru) * 2006-10-25 2010-06-30 Хрома Терапьютикс Лтд. Производные птеридина как ингибиторы polo-подобной киназы, применяющиеся при лечении рака

Also Published As

Publication number Publication date
EP2296662A1 (en) 2011-03-23
WO2009130453A1 (en) 2009-10-29
US20110190306A1 (en) 2011-08-04
JP2011518816A (ja) 2011-06-30

Similar Documents

Publication Publication Date Title
GB0807451D0 (en) Inhibitors of PLK
ZA201000318B (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
ZA201008808B (en) Novel phenylpyrazinones as kinase inhibitors
ZA201204246B (en) Kinase inhibitors
ZA201203842B (en) Kinase inhibitors
ZA201006719B (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
ZA201102423B (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
ZA201004942B (en) Ptrrolopyrazine kinase inhibitors
ZA201100898B (en) Novel inhibitors
PL2373157T3 (pl) Dyspersje zawierające inhibitory dioksygenazy hydroksyfenylopirogronianowej
IL212119A0 (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
ZA201004765B (en) Inhibitors of iap
ZA201102837B (en) Phosphodiestarase inhibitors
IL208916A0 (en) Inhibitors of jnk
GB0916010D0 (en) JMJD2 demethylase inhibitors
GB0621205D0 (en) Inhibitors of PLK
GB0807452D0 (en) PLK inhibitors
GB0914726D0 (en) Kinase inhibitors
GB0715614D0 (en) Inhibitors of plk
GB201019387D0 (en) Inhibitors
GB0816125D0 (en) Novel inhibitors
GB0903650D0 (en) Glyoalase inhibitors
GB0902661D0 (en) Inhibitors
GB0915927D0 (en) Novel inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)